{
  "version": "https://jsonfeed.org/version/1",
  "icon": "https://www.trackawesomelist.com/icon.png",
  "favicon": "https://www.trackawesomelist.com/favicon.ico",
  "language": "en",
  "title": "Track Awesome Glp1 Updates Daily",
  "_seo_title": "Track Awesome Glp1 (glp1guide/awesome-glp1) Updates Daily - Track Awesome List",
  "_site_title": "Track Awesome List",
  "description": "Awesome resources around the GLP1 Receptor Agonist class of treatments. Sponsored by GLP1.Guide",
  "home_page_url": "https://www.trackawesomelist.com/glp1guide/awesome-glp1/",
  "feed_url": "https://www.trackawesomelist.com/glp1guide/awesome-glp1/feed.json",
  "items": [
    {
      "id": "https://www.trackawesomelist.com/2024/02/20/",
      "title": "Awesome Glp1 Updates on Feb 20, 2024",
      "_short_title": "Feb 20, 2024",
      "_slug": "2024/02/20/",
      "summary": "4 awesome projects updated on Feb 20, 2024",
      "_filepath": "/content/2024/02/20/README.md",
      "url": "https://www.trackawesomelist.com/2024/02/20/",
      "date_published": "2024-02-20T07:14:32.000Z",
      "date_modified": "2024-02-20T07:14:32.000Z",
      "content_text": "\n\n### üßë‚Äçü§ù‚Äçüßë Trials\n\n*   [STEP1 Trial](https://www.nejm.org/doi/full/10.1056/NEJMoa2032183) (Semaglutide)\n    *   [On ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03548935)\n*   [Step2 Trial](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736\\(21\\)00213-0/abstract) (Semaglutide)\n*   [SURMOUNT-1 Trial](https://www.nejm.org/doi/full/10.1056/NEJMoa2206038) (Tirzepatide)\n*   [SURMOUNT-4 Trial](https://jamanetwork.com/journals/jama/fullarticle/2812936)",
      "content_html": "<h3><p>üßë‚Äçü§ù‚Äçüßë Trials</p>\n</h3>\n<ul>\n<li><a href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa2032183\" rel=\"noopener noreferrer\">STEP1 Trial</a> (Semaglutide)<ul>\n<li><a href=\"https://clinicaltrials.gov/study/NCT03548935\" rel=\"noopener noreferrer\">On ClinicalTrials.gov</a></li>\n</ul>\n</li>\n</ul>\n\n<ul>\n<li><a href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00213-0/abstract\" rel=\"noopener noreferrer\">Step2 Trial</a> (Semaglutide)</li>\n</ul>\n\n<ul>\n<li><a href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa2206038\" rel=\"noopener noreferrer\">SURMOUNT-1 Trial</a> (Tirzepatide)</li>\n</ul>\n\n<ul>\n<li><a href=\"https://jamanetwork.com/journals/jama/fullarticle/2812936\" rel=\"noopener noreferrer\">SURMOUNT-4 Trial</a></li>\n</ul>\n"
    }
  ]
}
